01 4Amgevita
02 2Hadlima
03 17Humira
04 6Imraldi
Main Therapeutic Indication : Immunology (Organ Transplant, Arthr...
Currency : USD
2017 Revenue in Millions : 18,427
2016 Revenue in Millions : 16,078
Growth (%) : 15
Main Therapeutic Indication : Immunology
Currency : USD
2020 Revenue in Millions : 19,832
2019 Revenue in Millions : 19,169
Growth (%) : 3
Main Therapeutic Indication : Immunology (Organ Transplant, Arthr...
Currency : USD
2016 Revenue in Millions : 16,078
2015 Revenue in Millions : 14,012
Growth (%) : 15
Main Therapeutic Indication : Immunology
Currency : USD
2021 Revenue in Millions : 20,694
2020 Revenue in Millions : 19,832
Growth (%) : 4
Main Therapeutic Indication : Immunology (Organ Transplant, Arthr...
Currency : USD
2015 Revenue in Millions : 12,543
2014 Revenue in Millions : 14,012
Growth (%) : 12%
Main Therapeutic Indication : Immunology
Currency : USD
2022 Revenue in Millions : 21,237
2021 Revenue in Millions : 20,694
Growth (%) : 3
Main Therapeutic Indication : Immunology
Currency : USD
2023 Revenue in Millions : 14,404
2022 Revenue in Millions : 21,237
Growth (%) : -32
Main Therapeutic Indication : Immunology (Organ Transplant, Arthr...
Currency : USD
2018 Revenue in Millions : 19,936
2017 Revenue in Millions : 18,427
Growth (%) : 8%
Main Therapeutic Indication : Immunology
Currency : USD
2019 Revenue in Millions : 19,169
2018 Revenue in Millions : 19,936
Growth (%) : -4
Main Therapeutic Indication : Immunology (Organ Transplant, Arthr...
Currency : USD
2014 Revenue in Millions : 17.70%
2013 Revenue in Millions :
Growth (%) :
